These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide. Kanwar JR, Gibbons J, Verma AK, Kanwar RK. Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171 [Abstract] [Full Text] [Related]
23. Tumor microenvironment-responsive cell-penetrating peptides: Design principle and precision delivery. Wang C, Wang B, Zhang Q, Zhang S. Colloids Surf B Biointerfaces; 2024 Oct; 242():114100. PubMed ID: 39024717 [Abstract] [Full Text] [Related]
25. The pharmacokinetics of cell-penetrating peptides. Sarko D, Beijer B, Garcia Boy R, Nothelfer EM, Leotta K, Eisenhut M, Altmann A, Haberkorn U, Mier W. Mol Pharm; 2010 Dec 06; 7(6):2224-31. PubMed ID: 20845937 [Abstract] [Full Text] [Related]
28. Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. Borrelli A, Tornesello AL, Tornesello ML, Buonaguro FM. Molecules; 2018 Jan 31; 23(2):. PubMed ID: 29385037 [Abstract] [Full Text] [Related]
29. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Nakase I, Akita H, Kogure K, Gräslund A, Langel U, Harashima H, Futaki S. Acc Chem Res; 2012 Jul 17; 45(7):1132-9. PubMed ID: 22208383 [Abstract] [Full Text] [Related]
30. Polymer Nanoparticles Modified with Photo- and pH-Dual-Responsive Polypeptides for Enhanced and Targeted Cancer Therapy. Yang Y, Xie X, Yang Y, Li Z, Yu F, Gong W, Li Y, Zhang H, Wang Z, Mei X. Mol Pharm; 2016 May 02; 13(5):1508-19. PubMed ID: 27043442 [Abstract] [Full Text] [Related]
31. Cell penetrating peptides: A concise review with emphasis on biomedical applications. Derakhshankhah H, Jafari S. Biomed Pharmacother; 2018 Dec 02; 108():1090-1096. PubMed ID: 30372809 [Abstract] [Full Text] [Related]
32. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties. Soler M, González-Bártulos M, Soriano-Castell D, Ribas X, Costas M, Tebar F, Massaguer A, Feliu L, Planas M. Org Biomol Chem; 2014 Mar 14; 12(10):1652-63. PubMed ID: 24480922 [Abstract] [Full Text] [Related]
33. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT. Gao W, Yang X, Lin Z, He B, Mei D, Wang D, Zhang H, Zhang H, Dai W, Wang X, Zhang Q. J Control Release; 2017 Sep 10; 261():174-186. PubMed ID: 28662902 [Abstract] [Full Text] [Related]
34. Influence of the Dabcyl group on the cellular uptake of cationic peptides: short oligoarginines as efficient cell-penetrating peptides. Szabó I, Illien F, Dókus LE, Yousef M, Baranyai Z, Bősze S, Ise S, Kawano K, Sagan S, Futaki S, Hudecz F, Bánóczi Z. Amino Acids; 2021 Jul 10; 53(7):1033-1049. PubMed ID: 34032919 [Abstract] [Full Text] [Related]
35. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies. Li H, Tsui TY, Ma W. Int J Mol Sci; 2015 Aug 18; 16(8):19518-36. PubMed ID: 26295227 [Abstract] [Full Text] [Related]
37. New generation of cell-penetrating peptides: Functionality and potential clinical application. Reissmann S, Filatova MP. J Pept Sci; 2021 May 18; 27(5):e3300. PubMed ID: 33615648 [Abstract] [Full Text] [Related]
38. Insights into cell penetrating peptide conjugated gold nanoparticles for internalization into bacterial cells. Kumar M, Tegge W, Wangoo N, Jain R, Sharma RK. Biophys Chem; 2018 Jun 18; 237():38-46. PubMed ID: 29656216 [Abstract] [Full Text] [Related]
39. The Current Role of Cell-Penetrating Peptides in Cancer Therapy. Feni L, Neundorf I. Adv Exp Med Biol; 2017 Jun 18; 1030():279-295. PubMed ID: 29081059 [Abstract] [Full Text] [Related]